Diabetic foot ulcers are a significant health care problem. Complications of foot ulcers are a leading cause of hospitalization and amputation in patients with diabetes mellitus. In response to a request from the Wound Healing Society, a panel of advisers, including physicians from academia and private practice, nurses, a podiatrist, a pedorthist, and a representative from industry, was selected to develop guidelines for the treatment of diabetic ulcers of the lower extremity.
METHODS
The approach used to develop guidelines was similar to that used by the Venous Ulcer Panel, also convened at the request of the Wound Healing Society. Those guidelines were presented on October 3, 2005 , at a conference at the National Institutes of Health (NIH). Previous guidelines, meta-analyses, PubMed, MEDLINE, EMBASE, The Cochrane Database of Systematic Reviews, recent reviews of diabetic ulcer treatment, and the Medicare/CMS consensus of usual treatment of chronic wounds were reviewed for evidence. Guidelines were formulated, the underlying principle(s) enumerated, and evidence references listed and coded. The code abbreviations for the evidence citations were as follows: There was a major difference between our approach to evidence citations and past approaches to evidence-based guidelines. Most past approaches relied only on publications regarding clinical human studies. Laboratory or animal studies were not cited. We have used well-controlled animal studies that present proof of principle, especially when a clinical series corroborated the laboratory results. Because of this variation, a different system was used to grade the weight of evidence supporting a given guideline. The strength of evidence supporting a guideline is listed as Level I, Level II, or Level III. The guideline levels are: 
GUIDELINES FOR OFFLOADING FOR TREATMENT OF DIABETIC ULCERS
Preamble: Diabetic ulceration may result from an increase in pressure on the diabetic foot because of foot deformity, limited joint mobility, and neuropathy. Offloading the area of high pressure has been the mainstay to prevent these problems.
Guideline #2.1: Protective footwear should be prescribed in any patient at risk for amputation (significant arterial insufficiency, significant neuropathy, previous amputation, previous ulcer formation, preulcerative callus, foot deformity, evidence of callus formation). (Level II)
Principle: The incidence of ulceration in diabetic patients at risk for ulceration can be reduced by using protective footwear.
Evidence:
1. Janisse D. The Therapeutic Shoe Bill: medicare coverage for prescription footwear for diabetic patients. Principle: (4.1.C) Wounds will heal in an environment that is adequately oxygenated. Oxygen delivery to the wound will be impaired if tissue perfusion is inadequate. Dehydration and factors that increase sympathetic tone such as cold, stress, or pain will decrease tissue perfusion. Cigarette smoking decreases tissue oxygen by peripheral vasoconstriction. For optimal tissue perfusion, these factors must be eliminated or minimized.
Evidence: Guideline #4.2: Initial debridement is required to remove the obvious necrotic tissue, excessive bacterial burden, and cellular burden of dead and senescent cells. Maintenance debridement is needed to maintain the appearance and readiness of the wound bed for healing. The health care provider can choose from a number of debridement methods including surgical, enzymatic, mechanical, biological, or autolytic. More than one debridement method may be appropriate. (Sharp surgical debridement is preferred; Level I.)
Principle: Necrotic tissue, excessive bacterial burden, senescent cells, and cellular debris can all inhibit wound healing. The method of debridement chosen may depend on the status of the wound, the capability of the health provider, the overall condition of the patient, and professional licensing restrictions. Principle: Irrigating and cleansing the wound removes loose impediments to wound healing. Sterile saline or water is usually recommended. Tap water should only be used if the water source is reliably clean. Experimental data suggest that a nontoxic surfactant may be useful as may fluid delivered by increased intermittent pressure.
Guideline #4.4: There should be an ongoing and consistent documentation of wound history, recurrence, and characteristics (location, size, base, exudates, condition of the surrounding skin, staging, and pain) to evaluate wound bed preparation. The rate of wound healing should be evaluated to determine whether treatment is optimal. (Level II)
Principle: Ongoing evaluations of wound bed preparation are necessary; if the ulcer is not healing at the expected rate, interventions for wound bed preparation need to be reassessed. The longer the duration of the ulcer, the more difficult it is to heal. If an ulcer is recurrent, etiology, patient education, or issues of prevention and long-term maintenance need to be reassessed. 
GUIDELINES FOR DRESSINGS IN THE TREATMENT OF DIABETIC ULCERS
Preamble: There is a plethora of choices for topical treatment of diabetic ulcers. Many dressings now combine wound bed preparation, i.e., debridement and/or antimicrobial activity, with moisture control. Guidelines are necessary to help the clinician make decisions regarding the value and best use of these advanced wound care products. Most dressings will be used in combination with offloading and protection of the foot. Principle: Because of their low unit cost, moist saline gauze dressings are often viewed as the least expensive and, therefore, most cost-effective dressing. However, when determining cost efficacy, it is important to take into consideration health care provider time, ease of use, and healing rate, as well as the unit cost of the dressing. Principle: Emerging therapies through recombinant technologies and cell-based devices may offer benefit and increase healing in selected patients or difficult wounds. These therapies are quite diverse and are discussed in detail in the Adjuvant Agents Guidelines.
Evidence:
Evidence references are detailed in the Adjuvant Agents (Topical, Device, Systemic Guidelines). Principle: Lengthening the Achilles tendon reduces pressure on forefoot plantar ulcers in patients with limited dorsiflexion and may be of benefit in healing certain diabetic foot ulcers.
Evidence:
